-+ 0.00%
-+ 0.00%
-+ 0.00%

Veru Inc. Publishes Corporate Presentation on Enobosarm-GLP-1 Obesity Program and Sabizabulin Atherosclerosis Development

Reuters·03/02/2026 14:39:06

Please log in to view news